Key facts
- This page summarizes Dr. Juan Camilo Arjona Ferreira's Form 4 filing for Organon & Co. (OGN).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 02 Apr 2025, 17:40.
Dr. Juan Camilo Arjona Ferreira - 31 Mar 2025 Form 4 Insider Report for Organon & Co. (OGN)
- Reporting relationship
- Head of R&D & CMO
- Issuer ticker
- OGN
- Reported as of
- 31 Mar 2025
- Net transaction value
- -$46,026
- SEC form
- 4
- Accepted by SEC
- 02 Apr 2025, 17:40:55 UTC
- Prior SEC filing
- 08 Nov 2024
- Next SEC filing
- 12 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tarnetta Jones, as Attorney-in-fact for Dr. Juan Camilo Arjona Ferreira
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Dr. Juan Camilo Arjona Ferreira filed Form 4 for Organon & Co. (OGN) on 02 Apr 2025.
Change
- Previous filing in this sequence was filed on 08 Nov 2024.
- Current net transaction value: -$46,026.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OGN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +8,865
- Change %
- +76%
- Price
- $0.000000
- Shares after
- 20,552
- Date
- 31 Mar 2025
- Ownership
- Direct
OGN
transaction
Common Stock
Tax liability
- Transaction value
- $46,026
- Shares
- -3,172
- Change %
- -15%
- Price
- $14.51
- Shares after
- 17,380
- Date
- 31 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OGN
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +198,019
- Change %
- Price
- $0.000000
- Shares after
- 198,019
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 198,019
- Exercise price
- $14.89
- Footnotes
- F2, F3
OGN
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +40,295
- Change %
- Price
- $0.000000
- Shares after
- 40,295
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,295
- Exercise price
- Footnotes
- F2, F4
OGN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -8,865
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 17,730
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,865
- Exercise price
- Footnotes
- F2, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
Footnote F2
Each RSU converts into one share of Organon common stock.
Footnote F3
The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028.
Footnote F4
The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028.
Footnote F5
On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day.